JPS53121921A - Instant mouth dischargeable capsule used to include 44*2**nitrophenyl**2*66 dimethyll8*55dicarbomethoxyy 1*44dihydropyridine - Google Patents

Instant mouth dischargeable capsule used to include 44*2**nitrophenyl**2*66 dimethyll8*55dicarbomethoxyy 1*44dihydropyridine

Info

Publication number
JPS53121921A
JPS53121921A JP2936178A JP2936178A JPS53121921A JP S53121921 A JPS53121921 A JP S53121921A JP 2936178 A JP2936178 A JP 2936178A JP 2936178 A JP2936178 A JP 2936178A JP S53121921 A JPS53121921 A JP S53121921A
Authority
JP
Japan
Prior art keywords
dimethyll8
dischargeable
nitrophenyl
capsule used
instant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2936178A
Other languages
Japanese (ja)
Inventor
Botsusaato Furiidoritsuhi
Fuaataa Urufu
Bauaa Kuruto
Haintsu Adamusu Kaaru
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25761638&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=JPS53121921(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from DE19722209526 external-priority patent/DE2209526C3/en
Application filed by Bayer AG filed Critical Bayer AG
Publication of JPS53121921A publication Critical patent/JPS53121921A/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S206/00—Special receptacle or package
    • Y10S206/828—Medicinal content
JP2936178A 1971-08-24 1978-03-16 Instant mouth dischargeable capsule used to include 44*2**nitrophenyl**2*66 dimethyll8*55dicarbomethoxyy 1*44dihydropyridine Pending JPS53121921A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE2142316 1971-08-24
DE19722209526 DE2209526C3 (en) 1972-02-29 1972-02-29 Coronary therapeutic agent in the form of gelatine capsules

Publications (1)

Publication Number Publication Date
JPS53121921A true JPS53121921A (en) 1978-10-24

Family

ID=25761638

Family Applications (2)

Application Number Title Priority Date Filing Date
JP8414772A Expired JPS5434048B2 (en) 1971-08-24 1972-08-24
JP2936178A Pending JPS53121921A (en) 1971-08-24 1978-03-16 Instant mouth dischargeable capsule used to include 44*2**nitrophenyl**2*66 dimethyll8*55dicarbomethoxyy 1*44dihydropyridine

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP8414772A Expired JPS5434048B2 (en) 1971-08-24 1972-08-24

Country Status (25)

Country Link
US (1) US3784684A (en)
JP (2) JPS5434048B2 (en)
KR (1) KR780000433B1 (en)
BE (1) BE787951A (en)
BG (1) BG27728A3 (en)
CA (1) CA981582A (en)
CY (1) CY918A (en)
DD (1) DD99729A5 (en)
DK (1) DK130628B (en)
EG (1) EG10633A (en)
ES (1) ES406047A1 (en)
FI (1) FI53922C (en)
FR (1) FR2150848B1 (en)
GB (1) GB1362627A (en)
HK (1) HK44877A (en)
IE (1) IE36891B1 (en)
IL (1) IL40165A (en)
KE (1) KE2756A (en)
LU (1) LU65929A1 (en)
MY (1) MY7800003A (en)
NL (1) NL176836C (en)
NO (1) NO138167C (en)
RO (1) RO88521B (en)
SG (1) SG34877G (en)
SU (1) SU432703A3 (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62116508A (en) * 1985-09-11 1987-05-28 シオノギ　ユーロープ　ベスローテン　フェンノートシャップ Capsule agent for chewing
JPH02501304A (en) * 1986-11-18 1990-05-10 フォルシュングゲゼルシャフト・ラウヘン・ウント・ゲスンドハイト・エムベーハー Capsules for oral administration containing nicotine-containing fluid medium
JPH0517356A (en) * 1990-11-29 1993-01-26 Nippon Kayaku Co Ltd Hard capsule agent
JPH11147819A (en) * 1997-09-10 1999-06-02 Takeda Chem Ind Ltd Stabilized medicinal preparation

Families Citing this family (85)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU432703A3 (en) * 1971-08-24 1974-06-15 Фридрих Боссерт, Вульф Фатер, Курт Бауер
ZA725808B (en) * 1971-08-24 1973-05-30 Bayer Ag A coronary agent in special form and processes for its manufacture
GB1481411A (en) * 1973-07-20 1977-07-27 Scherer Ltd R Pharmaceutical compositions
US4198391A (en) * 1973-07-20 1980-04-15 R. P. Scherer Ltd. Pharmaceutical compositions
ZA751102B (en) * 1974-02-22 1976-09-29 Wellcome Found Pharmaceutical preparations
US4002718A (en) * 1974-10-16 1977-01-11 Arnar-Stone Laboratories, Inc. Gelatin-encapsulated digoxin solutions and method of preparing the same
US4056610A (en) * 1975-04-09 1977-11-01 Minnesota Mining And Manufacturing Company Microcapsule insecticide composition
JPS52151724A (en) * 1976-06-07 1977-12-16 Takeda Chem Ind Ltd Hard shell gelatin capsule
GB1579818A (en) * 1977-06-07 1980-11-26 Yamanouchi Pharma Co Ltd Nifedipine-containing solid preparation composition
JPS5484023A (en) * 1977-12-19 1979-07-04 Teijin Ltd Soft capsule containing active vitamin d3, and its preparation
JPS5522645A (en) * 1978-08-07 1980-02-18 Fujisawa Pharmaceut Co Ltd Soft capsule for encapsulation of light-unstable compound
JPS5522631A (en) * 1978-08-07 1980-02-18 Ota Seiyaku Kk Readily absorbable nifedipine preparation
US5264446A (en) * 1980-09-09 1993-11-23 Bayer Aktiengesellschaft Solid medicament formulations containing nifedipine, and processes for their preparation
US4366145A (en) * 1981-06-24 1982-12-28 Sandoz, Inc. Soft gelatin capsule with a liquid ergot alkaloid center fill solution and method of preparation
JPS5939827A (en) * 1982-08-27 1984-03-05 Nitto Electric Ind Co Ltd External member for medical use
DE3307353C2 (en) * 1983-03-02 1985-01-31 R.P. Scherer GmbH, 6930 Eberbach Soft gelatin capsule containing polyethylene glycol and process for their production
GB8305693D0 (en) * 1983-03-02 1983-04-07 Scherer Ltd R P Pharmaceutical compositions
DE3307422A1 (en) * 1983-03-03 1984-09-06 Bayer Ag, 5090 Leverkusen LIQUID PREPARATIONS OF DIHYDROPYRIDINES, A METHOD FOR THE PRODUCTION THEREOF AND THEIR USE IN THE FIGHT AGAINST DISEASES
US4777048A (en) * 1983-07-07 1988-10-11 American Home Products Corporation Pharmaceutical composition containing a liquid lubricant
US4832952A (en) * 1983-07-07 1989-05-23 American Home Products Corporation Pharmaceutical composition containing a liquid lubricant
US4620974A (en) * 1983-07-07 1986-11-04 American Home Products Corporation Pharmaceutical composition containing a liquid lubricant
EP0143857B1 (en) * 1983-11-30 1988-04-06 Siegfried Aktiengesellschaft Therapeutic coronary composition in the form of soft gelatine capsules
DE3419129A1 (en) * 1984-05-23 1985-11-28 Bayer Ag, 5090 Leverkusen NIFEDIPINE PREPARATIONS AND METHOD FOR THE PRODUCTION THEREOF
DE3419130A1 (en) * 1984-05-23 1985-11-28 Bayer Ag, 5090 Leverkusen NIFEDIPINE COMBINATION PREPARATIONS AND METHOD FOR THEIR PRODUCTION
US5266581A (en) * 1984-07-04 1993-11-30 Bayer Aktiengesellschaft Solid composition containing dihydropyridine, PVP and PVPP
EP0175671A1 (en) * 1984-08-23 1986-03-26 Kuhlemann & Co. Pharmaceutical preparation and method for the administration of this pharmaceutical preparation
DE3438830A1 (en) * 1984-10-23 1986-04-30 Rentschler Arzneimittel PHARMACEUTICAL FORM CONTAINING NIFEDIPIN AND METHOD FOR THE PRODUCTION THEREOF
DE3532129A1 (en) * 1985-09-10 1987-03-12 Bayer Ag GELATINE CONTAINING SS CAROTINE
DE3544692A1 (en) * 1985-12-18 1987-06-19 Bayer Ag DIHYDROPYRIDINE SPRAY, METHOD FOR THE PRODUCTION THEREOF AND ITS PHARMACEUTICAL USE
US4689233A (en) * 1986-01-06 1987-08-25 Siegfried Aktiengesellschaft Coronary therapeutic agent in the form of soft gelatin capsules
US4656028A (en) * 1986-06-24 1987-04-07 Norcliff Thayer Inc. Encapsulated antacid
DE3636123A1 (en) * 1986-10-23 1988-05-05 Rentschler Arzneimittel ORAL ADMINISTRATIVE PREPARATIONS CONTAINING SINGLE DOSE FROM 10 TO 240 MG DIHYDROPYRIDINE
GB8629761D0 (en) * 1986-12-12 1987-01-21 Harris Pharma Ltd Capsules
ES2040697T3 (en) * 1986-12-18 1993-11-01 Kurt H. Prof. Dr. Bauer NIFEDIPINE CONCENTRATE STABILIZED AGAINST THE INFLUENCE OF LIGHT, AND PROCEDURE FOR ITS PREPARATION.
DE3714402A1 (en) * 1987-04-30 1988-11-10 Kali Chemie Pharma Gmbh DRUG FORMULATION
DE3738236A1 (en) * 1987-11-11 1989-05-24 Euro Celtique Sa BIT CAPSULE
US4954346A (en) * 1988-06-08 1990-09-04 Ciba-Geigy Corporation Orally administrable nifedipine solution in a solid light resistant dosage form
US4935243A (en) * 1988-12-19 1990-06-19 Pharmacaps, Inc. Chewable, edible soft gelatin capsule
US5431916A (en) * 1993-04-29 1995-07-11 The Procter & Gamble Company Pharmaceutical compositions and process of manufacture thereof
US6726930B1 (en) * 1993-09-09 2004-04-27 Penwest Pharmaceuticals Co. Sustained release heterodisperse hydrogel systems for insoluble drugs
US5773025A (en) * 1993-09-09 1998-06-30 Edward Mendell Co., Inc. Sustained release heterodisperse hydrogel systems--amorphous drugs
US5455046A (en) * 1993-09-09 1995-10-03 Edward Mendell Co., Inc. Sustained release heterodisperse hydrogel systems for insoluble drugs
US5641512A (en) * 1995-03-29 1997-06-24 The Procter & Gamble Company Soft gelatin capsule compositions
DE69732412T2 (en) * 1996-04-12 2006-01-05 Novadel Pharma Inc. BUKALES, POLAR SPRAY
CA2231195C (en) 1996-07-08 2003-01-21 Edward Mendell Co., Inc. Sustained release matrix for high-dose insoluble drugs
US20040136914A1 (en) * 1997-10-01 2004-07-15 Dugger Harry A. Buccal, polar and non-polar spray containing ondansetron
WO1999016417A1 (en) * 1997-10-01 1999-04-08 Flemington Pharmaceutical Corporation Buccal, polar and non-polar spray or capsule
US20030077228A1 (en) * 1997-10-01 2003-04-24 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating endocrine disorders
US20030190286A1 (en) * 1997-10-01 2003-10-09 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating allergies or asthma
US7632517B2 (en) * 1997-10-01 2009-12-15 Novadel Pharma Inc. Buccal, polar and non-polar spray containing zolpidem
US20030082107A1 (en) * 1997-10-01 2003-05-01 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating an infectious disease or cancer
US20030077227A1 (en) * 1997-10-01 2003-04-24 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the central nervous system
US20030185761A1 (en) * 1997-10-01 2003-10-02 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating pain
US20030095925A1 (en) * 1997-10-01 2003-05-22 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating metabolic disorders
US20050163719A1 (en) * 1997-10-01 2005-07-28 Dugger Harry A.Iii Buccal, polar and non-polar spray containing diazepam
US20030095927A1 (en) * 1997-10-01 2003-05-22 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating muscular and skeletal disorders
US20050180923A1 (en) * 1997-10-01 2005-08-18 Dugger Harry A.Iii Buccal, polar and non-polar spray containing testosterone
US20050287075A1 (en) * 1997-10-01 2005-12-29 Dugger Harry A Iii Buccal, polar and non-polar spray or capsule containing drugs for treating pain
US20090162300A1 (en) * 1997-10-01 2009-06-25 Dugger Iii Harry A Buccal, polar and non-polar spray containing alprazolam
US20040136915A1 (en) * 1997-10-01 2004-07-15 Dugger Harry A. Buccal, polar and non-polar spray containing atropine
US20030095926A1 (en) * 1997-10-01 2003-05-22 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the gastrointestinal tract or urinary tract
US20030077229A1 (en) * 1997-10-01 2003-04-24 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing cardiovascular or renal drugs
US20040141923A1 (en) * 1997-10-01 2004-07-22 Dugger Harry A. Buccal, polar and non-polar spray containing alprazolam
US20050281752A1 (en) * 1997-10-01 2005-12-22 Dugger Harry A Iii Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the central nervous system
US20050002867A1 (en) * 1997-10-01 2005-01-06 Novadel Pharma Inc. Buccal, polar and non-polar sprays containing propofol
US20040136913A1 (en) * 1997-10-01 2004-07-15 Dugger Harry A. Buccal, polar and non-polar spray containing sumatriptan
US6056977A (en) * 1997-10-15 2000-05-02 Edward Mendell Co., Inc. Once-a-day controlled release sulfonylurea formulation
US20030102246A1 (en) * 1999-03-20 2003-06-05 Lts Lohmann Therapie-Systeme Ag Method for improving the stability of stored and/or used light-sensitive therapeutic systems or components thereof
DE60045101D1 (en) 1999-08-31 2010-11-25 Chugai Pharmaceutical Co Ltd CAPSULES
ES2304980T3 (en) * 1999-09-30 2008-11-01 Penwest Pharmaceuticals Co. SUSTAINED LIBERATION MATRIX SYSTEMS FOR HIGHLY SOLUBLE PHARMACOS.
WO2002087543A1 (en) * 2001-05-01 2002-11-07 Biozone Laboratories, Inc. Sustained release formulations for nifedipine, dextromethorphan, and danazol
US20030070679A1 (en) * 2001-06-01 2003-04-17 Boehringer Ingelheim Pharma Kg Capsules containing inhalable tiotropium
DE60319355T3 (en) 2002-04-25 2012-01-05 Banner Pharmacaps Inc. CHICKEN SOAP CAPSULES
EP1502588B1 (en) * 2002-05-09 2013-03-06 Chugai Seiyaku Kabushiki Kaisha Light-stabilized soft capsule for formulations
SI1944029T1 (en) * 2005-10-31 2012-03-30 Kowa Co Pharmaceutical preparation having excellent photostability
CA2649895C (en) * 2006-04-19 2013-03-26 Novadel Pharma Inc. Stable hydroalcoholic oral spray formulations and methods
EP2124897A4 (en) * 2006-12-22 2012-05-09 Novadel Pharma Inc Stable anti-nausea oral spray formulations and methods
WO2008141264A1 (en) * 2007-05-10 2008-11-20 Novadel Pharma Inc. Anti-insomnia compositions and methods
US7985325B2 (en) * 2007-10-30 2011-07-26 Novellus Systems, Inc. Closed contact electroplating cup assembly
WO2009091622A1 (en) * 2008-01-18 2009-07-23 Dow Global Technologies Inc. Method to enhance aqueous solubility of poorly soluble actives using methoxypolyethylene glycol
US20110305758A1 (en) * 2009-01-29 2011-12-15 Mitsuhiro Matono Orally disintegrating tablet having inner core
CN102160872A (en) 2010-02-23 2011-08-24 天津天士力制药股份有限公司 Compound salvia dropping pill capsules
TWI571257B (en) * 2011-02-23 2017-02-21 Tasly Pharmaceutical Group Co Capsule preparation
CN116440096A (en) 2018-05-14 2023-07-18 比利时胶囊公司 Capsule containing opacifier
AU2019285170A1 (en) 2018-06-14 2021-01-28 Astrazeneca Uk Limited Methods for lowering blood pressure with a dihydropyridine-type calcium channel blocker pharmaceutical composition

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2870061A (en) * 1956-11-08 1959-01-20 Mead Johnson & Co Concentrates of dialkyl sulfosuccinates
US3155587A (en) * 1963-01-23 1964-11-03 American Cyanamid Co Stable liquid preparations of 7-chlorotetracycline
DE1670827C3 (en) * 1967-03-20 1974-10-24 Bayer Ag, 5090 Leverkusen 4- (2'-nitrophenyl) -2,6-dimethyl-3,5-dicarbmethoxy-1,4-dihydropyridine
SU432703A3 (en) * 1971-08-24 1974-06-15 Фридрих Боссерт, Вульф Фатер, Курт Бауер

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62116508A (en) * 1985-09-11 1987-05-28 シオノギ　ユーロープ　ベスローテン　フェンノートシャップ Capsule agent for chewing
JPH02501304A (en) * 1986-11-18 1990-05-10 フォルシュングゲゼルシャフト・ラウヘン・ウント・ゲスンドハイト・エムベーハー Capsules for oral administration containing nicotine-containing fluid medium
JPH0517356A (en) * 1990-11-29 1993-01-26 Nippon Kayaku Co Ltd Hard capsule agent
JPH11147819A (en) * 1997-09-10 1999-06-02 Takeda Chem Ind Ltd Stabilized medicinal preparation

Also Published As

Publication number Publication date
ES406047A1 (en) 1981-08-16
MY7800003A (en) 1978-12-31
US3784684A (en) 1974-01-08
SU432703A3 (en) 1974-06-15
HK44877A (en) 1977-09-09
FR2150848B1 (en) 1976-04-16
RO88521A (en) 1987-04-30
CA981582A (en) 1976-01-13
NL176836C (en) 1985-06-17
JPS4828621A (en) 1973-04-16
FI53922B (en) 1978-05-31
IE36891L (en) 1973-02-24
DK130628B (en) 1975-03-17
CY918A (en) 1977-12-23
KE2756A (en) 1977-10-14
LU65929A1 (en) 1973-01-15
BE787951A (en) 1973-02-26
DD99729A5 (en) 1973-08-20
BG27728A3 (en) 1979-12-12
IL40165A (en) 1975-03-13
NO138167B (en) 1978-04-10
EG10633A (en) 1976-08-31
GB1362627A (en) 1974-08-07
JPS5434048B2 (en) 1979-10-24
FR2150848A1 (en) 1973-04-13
KR780000433B1 (en) 1978-10-14
NO138167C (en) 1978-07-26
NL7211565A (en) 1973-02-27
FI53922C (en) 1979-09-07
IL40165A0 (en) 1972-10-29
RO88521B (en) 1987-05-01
SG34877G (en) 1987-04-03
IE36891B1 (en) 1977-03-16
NL176836B (en) 1985-01-16
DK130628C (en) 1975-08-25

Similar Documents

Publication Publication Date Title
JPS53121921A (en) Instant mouth dischargeable capsule used to include 44*2**nitrophenyl**2*66 dimethyll8*55dicarbomethoxyy 1*44dihydropyridine
PH11217A (en) Denture cleanser
GB1372932A (en) Anti-caries compositions
GB1551055A (en) Capsule syringes
ZA733996B (en) Mouth cleansing preparation
PH11328A (en) Dental product
ZA751007B (en) Oral pharmaceutical preparation
GB1372785A (en) Enemata administering devices
CA987598A (en) Cleansing of dentures
HK39080A (en) Oral hygiene compositions
ZA721192B (en) Dental unit
JPS54147938A (en) Oral hydiene enzyme composition
YU36774A (en) Hard-gelatine-type capsule
GB1373003A (en) Dentifrice composition
IL46682A (en) Pharmaceutical capsules containing difoxin
ZA728900B (en) Dentifrice
ZM5372A1 (en) Stable dentifrice
PH11404A (en) 2(n-substituted-phenylamino)-imidazolines-(2)and pharmaceutical compositions thereof
ZA725918B (en) Hypoglycemic compositions containing benzhydryllactamimide derivatives
ZA717543B (en) Preparation of n-((1-ethyl-pyrrolidinyl-2-)-methyl-2-methoxy-5)-sulphamoyl-benzamide
IL39035A (en) Artificial dentures
ZA723487B (en) Dental cream
ZA745332B (en) Oral preparations
CA1031260A (en) Pharmaceutical capsule shell compositions
ZA727380B (en) Dental compositions